The Current Ratio as of September 2024 (TTM) for SpringWorks Therapeutics, Inc. (SWTX) is 7.91

According to SpringWorks Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.91. This represents a change of 6.35% compared to the average of 7.44 of the last 4 quarters.

SpringWorks Therapeutics, Inc. (SWTX) Historical Current Ratio (quarterly & annually)

How has SWTX Current Ratio performed in the past?

The mean historical Current Ratio of SpringWorks Therapeutics, Inc. over the last ten years is 16.67. The current 7.91 Current Ratio has changed 4.65% with respect to the historical average. Over the past ten years (40 quarters), SWTX's Current Ratio was at its highest in in the March 2020 quarter at 36.55. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

SpringWorks Therapeutics, Inc. (SWTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of SpringWorks Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

SpringWorks Therapeutics, Inc. (SWTX) Average Current Ratio

How has SWTX Current Ratio performed in the past?

The current Current Ratio of SpringWorks Therapeutics, Inc. (SWTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

SpringWorks Therapeutics, Inc. (SWTX) Current Ratio vs. Peers

How is SWTX’s Current Ratio compared to its peers?

SpringWorks Therapeutics, Inc.’s Current Ratio is less than Relay Therapeutics, Inc. (15.64), greater than Stoke Therapeutics, Inc. (6.67), less than Pliant Therapeutics, Inc. (14.47), greater than Black Diamond Therapeutics, Inc. (6.87), greater than Arvinas, Inc. (3.62), greater than Day One Biopharmaceuticals, Inc. (4.09), greater than Mirati Therapeutics, Inc. (7.54), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than Terns Pharmaceuticals, Inc. (21.02), greater than Apellis Pharmaceuticals, Inc. (5.08), greater than TCR2 Therapeutics Inc. (2.96), less than Revolution Medicines, Inc. (15.42), greater than Atreca, Inc. (1.58), greater than Passage Bio, Inc. (7.67), less than Cerevel Therapeutics Holdings, Inc. (10.22), less than Avidity Biosciences, Inc. (15.78), greater than Blueprint Medicines Corporation (3.71), greater than Sana Biotechnology, Inc. (5.20), less than Kymera Therapeutics, Inc. (8.45), greater than Monte Rosa Therapeutics, Inc. (6.56),

Build a custom stock screener for SpringWorks Therapeutics, Inc. (SWTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like SpringWorks Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

SpringWorks Therapeutics, Inc. (SWTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like SpringWorks Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.